ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2018

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer.

A Kron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.